EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Long‐term recovery in critically ill COVID ‐19 survivors: A prospective cohort study

Ingrid Didriksson iD, Attila Frigyesi, Martin Spångfors, Märta Leffler iD, Anton Reepalu, Anna C Nilsson, Martin Annborn, Anna Lybeck iD, Hans Friberg, Gisela Lilja

Acta Anaesthesiologica Scandinavica · 2025

DOI: 10.1111/aas.14550 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2025. Verfasst von Ingrid Didriksson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Anaesthesiology and Intensive Care, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: COVID-19, Critical Illness, Quality of Life, Survivors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hjärt-Lungfonden, Region Skåne, Swedish National Health Service.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long‐term recovery following critical COVID‐19 has not been sufficiently studied.

Objective

The primary objective was to describe changes in functional outcome and Health‐Related Quality of Life (HRQoL) between 3 and 12 months in critically ill COVID‐19 survivors. The secondary objective was to investigate factors associated with good functional outcome and HRQoL at 12 months.

Methods

Prospective multicentre cohort study including critically ill COVID‐19 patients admitted to six intensive care units in Sweden between May 2020 and May 2021. Surviving patients were invited to face‐to‐face follow‐ups at 3 and 12 months. Functional outcome was assessed using the Glasgow Outcome Scale Extended (GOSE), ranging from 1 to 8. Physical and mental HRQoL was assessed by the physical component summary (PCS) and mental component summary (MCS) scores of the Short form health survey version 2 (SF‐36v2®). Multivariable logistic regression models were used to identify factors associated with good functional outcome (GOSE ≥7) and good physical and mental HRQoL (PCS and MCS ≥45) at 12 months.

Results

The percentage of participants with a good functional outcome increased from 35% to 64% between 3 and 12 months ( p < .001). Mean PCS improved from 40 to 44 between 3 and 12 months ( p < .001), while the mean MCS was within the normal range at 3 months, with no change at 12 months (46 vs. 48, p = .05). Increasing age was associated with a good functional outcome. Lower clinical frailty and absence of diabetes mellitus were associated with a good PCS. A shorter duration of mechanical ventilation was associated with a good outcome for all three outcome measures.

Conclusion

Survivors of critical COVID‐19 showed improved functional outcome and physical HRQoL from 3 to 12 months post‐ICU. A shorter duration of mechanical ventilation is associated with good functional outcome and good HRQoL, while older age is associated with good functional outcome. Younger patients and those with comorbidities or higher frailty may require targeted follow‐up and rehabilitation. Study registration ClinicalTrials.gov Identifier: NCT04974775 , registered April 28, 2020.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Critical IllnessQuality of LifeSurvivorsHumansMaleFemaleProspective StudiesAgedMiddle AgedIntensive Care UnitsSwedenRecovery of FunctionCohort StudiesAged, 80 and overRespiration, ArtificialGlasgow Outcome Scale

Stichwörter der Autor:innen

COVID‐19Glasgow outcome scale‐extendedhealth‐related quality of lifepost‐COVID‐19 conditionpost‐intensive care syndrome

Autor:innen und Institutionen

  • Department of Clinical Sciences, Anaesthesiology and Intensive Care, Lund University, Lund, Sweden.
  • Skåne University Hospital, Intensive and Perioperative Care, Malmö, Sweden.
  • Skåne University Hospital, Intensive and Perioperative Care, Lund, Sweden.
  • Kristianstad Hospital, Anaesthesia, and Intensive Care, Kristianstad, Sweden.
  • Department of Infectious Diseases, Skåne University Hospital, Malmö, Sweden.
  • Department of Translational Medicine, Lund University, Malmö, Sweden.

ORCID-Profile: Ingrid Didriksson, Märta Leffler, Anna Lybeck

Förderung

  • Hjärt-Lungfonden
  • Region Skåne
  • Swedish National Health Service

Zitieren

APA

Didriksson, I., Frigyesi, A., Spångfors, M., Leffler, M., Reepalu, A., Nilsson, A. C., Annborn, M., Lybeck, A., Friberg, H., & Lilja, G. (2025). Long‐term recovery in critically ill COVID ‐19 survivors: A prospective cohort study. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.14550

Vancouver

Didriksson I, Frigyesi A, Spångfors M, Leffler M, Reepalu A, Nilsson AC, et al. Long‐term recovery in critically ill COVID ‐19 survivors: A prospective cohort study. Acta Anaesthesiologica Scandinavica. 2025. doi:10.1111/aas.14550

BibTeX
@article{Didriksson2025,
  author = {Didriksson, Ingrid and Frigyesi, Attila and Spångfors, Martin and Leffler, Märta and Reepalu, Anton and Nilsson, Anna C and Annborn, Martin and Lybeck, Anna and Friberg, Hans and Lilja, Gisela},
  title = {Long‐term recovery in critically ill COVID ‐19 survivors: A prospective cohort study},
  journal = {Acta Anaesthesiologica Scandinavica},
  year = {2025},
  doi = {10.1111/aas.14550}
}
Kostenlos starten →